시장보고서
상품코드
1975049

검체 채취 카드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Specimen Collection Cards Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 215 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

검체 채취 카드 시장 규모는 2025년 5억 281만 달러에서 2034년에는 8억 1,340만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 5.49%로 성장할 전망입니다.

세계 검체 채취 카드 시장은 신뢰할 수 있는 저비용의 생물학적 시료 채취 및 운송에 대한 수요 증가를 배경으로 꾸준히 성장하고 있습니다. 신생아 선별검사, 감염성 질환 검출, 유전자 분석에 대한 건조혈흔(DBS) 검사의 채택이 증가하면서 시장 성장에 크게 기여하고 있습니다. 조기 질병 진단에 대한 인식이 높아지고 개발도상국의 공중보건 감시 프로그램이 확대되면서 검체 채취 카드에 대한 수요가 더욱 증가하고 있습니다.

주요 성장 요인으로는 진단 기술의 발전, 만성질환 및 감염성 질환 증가, 원격의료 및 원격 검사 솔루션의 확대 등을 꼽을 수 있습니다. 제약사 및 생명공학 기업은 편의성과 안정성의 장점으로 인해 임상시험에서 검체 채취 카드의 사용을 확대하고 있습니다. 또한 분산형 임상연구에 대한 규제적 지원이 강화되면서 병원, 진단검사실, 연구기관에서 채택이 증가하고 있습니다.

향후 전망으로는 카드 소재의 혁신, 검체 보관 능력의 향상, 검사실의 자동화 통합이 시장에 긍정적인 영향을 미칠 것으로 예측됩니다. 재택 검사 키트와 현장 진단에 대한 수요 증가는 새로운 성장 기회를 창출할 것입니다. 의료 시스템이 비용 효율성과 환자 접근성 향상에 중점을 두고 있는 가운데, 검체 채취 카드는 전 세계 현대 진단 워크플로우의 중요한 구성 요소가 될 전망입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 검체 채취 카드 시장 : 표본 유형별

제5장 세계의 검체 채취 카드 시장 : 소재별

제6장 세계의 검체 채취 카드 시장 : 제품별

제7장 세계의 검체 채취 카드 시장 : 용도별

제8장 세계의 검체 채취 카드 시장 : 유통 채널별

제9장 세계의 검체 채취 카드 시장 : 최종 사용 채널별

제10장 세계의 검체 채취 카드 시장 : 지역별

제11장 경쟁 구도

제12장 기업 개요

KSA 26.04.01

The Specimen Collection Cards Market size is expected to reach USD 813.40 Million in 2034 from USD 502.81 Million (2025) growing at a CAGR of 5.49% during 2026-2034.

The Global Specimen Collection Cards Market is witnessing steady expansion driven by the growing need for reliable, low-cost biological sample collection and transportation. Increasing adoption of dried blood spot (DBS) testing in newborn screening, infectious disease detection, and genetic analysis is significantly contributing to market growth. Rising awareness of early disease diagnosis and the expansion of public health surveillance programs across developing economies are further supporting demand for specimen collection cards.

Key growth drivers include advancements in diagnostic technologies, the increasing prevalence of chronic and infectious diseases, and the expansion of telemedicine and remote testing solutions. Pharmaceutical and biotechnology companies are increasingly utilizing specimen collection cards in clinical trials due to their convenience and stability advantages. Additionally, improved regulatory support for decentralized clinical research is strengthening adoption across hospitals, diagnostic laboratories, and research institutions.

Looking ahead, the market is expected to benefit from innovations in card materials, enhanced sample preservation capabilities, and automation integration in laboratories. Growing demand for home-based testing kits and point-of-care diagnostics will create new growth opportunities. As healthcare systems emphasize cost efficiency and improved patient accessibility, specimen collection cards are poised to become a critical component of modern diagnostic workflows worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Specimen

  • Blood
  • Saliva
  • Urine
  • Buccal Cells
  • Others

By Material

  • Cotton & Cellulose-based
  • Fiber-based
  • Others

By Product

  • Whatman 903
  • Ahlstrom 226
  • FTA
  • Others

By Application

  • New Born Screening (NBS)
  • Infectious Diseases Testing
  • Therapeutic Drug Monitoring
  • Forensics
  • Research
  • Wellbeing/Health Monitoring
  • Other Applications

By Distribution Channel

  • Online
  • Offline

By End Use Channel

  • Hospitals & Clinics
  • Diagnostics Centers
  • Others

COMPANIES PROFILED

  • Qiagen, PerkinElmer Inc, DBS System SA, Danaher Corporation, Eastern Business Forms Inc, Ahlstrom, Archimed Life Science GmbH, GenTegra LLC, FortiusBio, Centogene NV
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY TYPE OF SPECIMEN 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type Of Specimen
  • 4.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Buccal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material
  • 5.2. Cotton & Cellulose-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Fiber-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Product
  • 6.2. Whatman 903 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ahlstrom 226 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. FTA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. New Born Screening (NBS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.7. Wellbeing/Health Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Distribution Channel
  • 8.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY END USE CHANNEL 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast End Use Channel
  • 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL SPECIMEN COLLECTION CARDS MARKET: BY REGION 2022-2034(USD MN)

  • 10.1. Regional Outlook
  • 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.2.1 By Type Of Specimen
    • 10.2.2 By Material
    • 10.2.3 By Product
    • 10.2.4 By Application
    • 10.2.5 By Distribution Channel
    • 10.2.6 By End Use Channel
    • 10.2.7 United States
    • 10.2.8 Canada
    • 10.2.9 Mexico
  • 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.3.1 By Type Of Specimen
    • 10.3.2 By Material
    • 10.3.3 By Product
    • 10.3.4 By Application
    • 10.3.5 By Distribution Channel
    • 10.3.6 By End Use Channel
    • 10.3.7 United Kingdom
    • 10.3.8 France
    • 10.3.9 Germany
    • 10.3.10 Italy
    • 10.3.11 Russia
    • 10.3.12 Rest Of Europe
  • 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.4.1 By Type Of Specimen
    • 10.4.2 By Material
    • 10.4.3 By Product
    • 10.4.4 By Application
    • 10.4.5 By Distribution Channel
    • 10.4.6 By End Use Channel
    • 10.4.7 India
    • 10.4.8 Japan
    • 10.4.9 South Korea
    • 10.4.10 Australia
    • 10.4.11 South East Asia
    • 10.4.12 Rest Of Asia Pacific
  • 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.5.1 By Type Of Specimen
    • 10.5.2 By Material
    • 10.5.3 By Product
    • 10.5.4 By Application
    • 10.5.5 By Distribution Channel
    • 10.5.6 By End Use Channel
    • 10.5.7 Brazil
    • 10.5.8 Argentina
    • 10.5.9 Peru
    • 10.5.10 Chile
    • 10.5.11 South East Asia
    • 10.5.12 Rest of Latin America
  • 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.6.1 By Type Of Specimen
    • 10.6.2 By Material
    • 10.6.3 By Product
    • 10.6.4 By Application
    • 10.6.5 By Distribution Channel
    • 10.6.6 By End Use Channel
    • 10.6.7 Saudi Arabia
    • 10.6.8 UAE
    • 10.6.9 Israel
    • 10.6.10 South Africa
    • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

  • 11.1. Recent Developments
  • 11.2. Company Categorization
  • 11.3. Supply Chain & Channel Partners (based on availability)
  • 11.4. Market Share & Positioning Analysis (based on availability)
  • 11.5. Vendor Landscape (based on availability)
  • 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL SPECIMEN COLLECTION CARDS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Company Profiles
    • 12.2.1 Qiagen
    • 12.2.2 PerkinElmer Inc
    • 12.2.3 DBS System SA
    • 12.2.4 Danaher Corporation
    • 12.2.5 Eastern Business Forms Inc
    • 12.2.6 Ahlstrom
    • 12.2.7 Archimed Life Science GmbH
    • 12.2.8 GenTegra LLC
    • 12.2.9 FortiusBio
    • 12.2.10 Centogene N.V
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제